Hormonal health

Inositol vs Metformin for PCOS: Comparing Evidence

Save

Metformin is a guideline-recommended prescription for the metabolic and menstrual features of PCOS, while inositol is a better-tolerated supplement backed by smaller, weaker trials. Small comparisons suggest similar effects on cycles and insulin, but leading guidelines judge inositol's evidence too limited to recommend it as a specific treatment.

Last updated: July 2026

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

How are inositol and metformin similar?

Inositol and metformin both work on insulin resistance, which drives much of PCOS for most people who have it, according to the Endocrine Society and the 2023 international guideline 12. Metformin lowers glucose output from the liver and improves insulin sensitivity; inositol is a naturally occurring compound involved in insulin signaling, sold mainly as myo-inositol.

Because PCOS affects roughly 1 in 10 women of reproductive age, interest in gentler options is high 4. Both approaches aim to lower circulating insulin, which can ease androgen excess and support more regular cycles. Both also work best alongside the nutrition and activity changes that address insulin resistance at its root, rather than replacing them.

What does the evidence say about metformin?

Metformin has the deeper evidence base of the two, with guideline backing from the 2023 international guideline, ACOG, and the Endocrine Society for metabolic and menstrual outcomes 123. It can lower fasting insulin, support modest weight change, and slow progression toward type 2 diabetes, which PCOS raises severalfold.

For fertility it is comparatively weak: a large trial found metformin alone produced a live birth in about 7 in 100 women, well below dedicated ovulation medicines 5. Metformin's main downside is gastrointestinal upset, which affects many users early on. People weighing it often review the full range of metformin side effects first, since tolerance varies widely from person to person.

What does the evidence say about inositol?

Inositol's evidence is thinner and less consistent than metformin's, drawn largely from small trials of varying quality. The 2023 international guideline concluded that inositol may be considered but that the evidence is too limited to recommend it as a specific PCOS therapy 1.

Small studies suggest inositol can improve insulin measures and menstrual regularity, and it is generally well tolerated, with fewer digestive complaints than metformin. Because supplements are not regulated like prescription drugs, purity and dose can vary between products. For the metabolic rationale, the overlap with inositol for insulin resistance is where most of the interest sits — though enthusiasm online often outpaces what the trials actually demonstrate.

How do you choose between them?

Choosing comes down to goals, tolerance, cost, and how much proven data matters to you. Someone with clear metabolic risk or prediabetes may lean toward metformin's stronger evidence, while someone who cannot tolerate its side effects — or who prefers an over-the-counter option — may try inositol knowing the data are weaker 1.

Neither is a substitute for foundational habits, and modest weight change of about 5% to 10% can improve cycles regardless of which is chosen 3. Life stage matters too: in adolescence, guidelines favor lifestyle first and use either agent cautiously, while across the perimenopausal transition metabolic risks persist even as cycles shift 1. Comparing them honestly is more useful than chasing a single winner.

When PCOS treatment choices need a clinician

A primary care clinician, gynecologist, or endocrinologist can weigh your labs, symptoms, and preferences and help you decide whether metformin, inositol, or neither makes sense right now. Because the two are sometimes even used together, an either-or framing rarely captures the real choice.

Since PCOS treatment options extend well beyond insulin-focused approaches, a broader conversation usually serves you better. Understanding how PCOS is diagnosed also helps you interpret which features are driving your symptoms. Gale can help you prepare for that conversation.

Common questions

The honest answer is that we do not yet know with confidence. Small trials suggest inositol and metformin may have broadly similar effects on cycles and insulin, but the studies are limited in size and quality. Metformin has the stronger evidence base and formal guideline backing, so it remains the better-studied choice even if inositol appeals for other reasons.

Some people do, and a clinician can advise whether combining them makes sense for your situation. There is no strong evidence that the combination is clearly better than either alone, so the decision usually comes down to tolerance, goals, and preference rather than proven synergy.

Inositol tends to cause fewer digestive side effects and is generally well tolerated. That said, supplements are not regulated as tightly as prescription medicines, so product quality and dose can vary. Better tolerated is not the same as more effective, which is where the evidence gap matters.

Neither is a first-line fertility treatment. Dedicated ovulation medicines outperform metformin for live births, and inositol's fertility evidence is limited. If pregnancy is the goal, a clinician can compare approaches suited to your cycles and history.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

When PCOS needs a clinician's input

  • —Periods that disappear for more than three months, or unusually heavy bleeding, are a reason to seek clinician review to protect the uterine lining.
  • —New excess hair growth, hair thinning, or a sudden change in acne is a reason to arrange a clinician visit for a hormone check.
  • —Ongoing thirst, frequent urination, or persistent fatigue can signal rising blood sugar and are a reason to seek prompt medical review.
  • —Supplements that promise dramatic PCOS cures are a reason to pause and review the claims with a clinician before spending money.

This article is general health education, not medical advice. Whether inositol, metformin, both, or neither suits you depends on your health history and goals, and should be decided with a primary care clinician, gynecologist, or endocrinologist.

References

  1. 1.Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/clinem/dgad463 ✓2023 international PCOS guideline: insulin resistance as a core driver, its assessment of inositol as insufficiently evidenced to recommend as a specific therapy, metformin's recommended metabolic and menstrual role, and staged adolescent-to-midlife management.
  2. 2.Legro RS, et al. (Endocrine Society) (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2013-2350 ✓Endocrine Society PCOS guideline: role of insulin resistance and metformin in PCOS management.
  3. 3.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656 ✓ACOG Practice Bulletin No. 194: metformin and lifestyle change for PCOS, including the benefit of modest (about 5%) weight loss on cycles.
  4. 4.Office on Women's Health (U.S. HHS) (2025). Polycystic ovary syndrome. Office on Women's Health (womenshealth.gov), U.S. HHS. link ✓Office on Women's Health PCOS overview: PCOS prevalence and insulin-resistance summary for patients.
  5. 5.Legro RS, Barnhart HX, Schlaff WD, et al. / Cooperative Multicenter Reproductive Medicine Network (2007). Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine. doi:10.1056/NEJMoa063971 ✓PPCOS randomized trial (NEJM 2007): comparatively low live-birth rate with metformin alone (about 7%) versus ovulation induction.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library